NewLink Genetics Corp (NASDAQ:NLNK)

7.13
Delayed Data
As of Feb 20
 +0.02 / +0.28%
Today’s Change
5.90
Today|||52-Week Range
25.17
-12.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues1.1M172.6M68.5M35.8M
 
 
 
 
 
Depreciation And Amortization891.0K1.1M1.6M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses31.3M53.9M100.5M112.8M
 
 
 
 
 
Research And Development22.7M35.7M71.4M82.2M
 
 
 
 
 
Total Operating Expenses32.2M55.0M102.1M114.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-31.1M117.6M-33.6M-79.2M
 
 
 
 
 
Extraordinary Charge0.00--0.00-11.6M
 
 
Interest Expense On Debt33.0K26.0K105.0K22.0K
 
 
 
 
 
Other Expenses112.0K0.00-14.0K32.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.1M117.6M-33.6M-90.5M
 
 
 
 
 
Income Taxes-130.0K-14.8M-6.7M-5.4M
 
 
 
 
 
Net Income-31.2M102.9M-40.4M-85.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.3M27.8M28.6M29.0M
 
 
 
 
 
Shares To Calculate EPS Diluted25.3M31.0M28.6M29.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.23$3.32-$1.41-$2.94
 
 
 
 
 
EPS Diluted-$1.23$3.32-$1.41-$2.94